call-us :+919958984431

Company Profile

Biogen India, located in the capital city of India, New Delhi, takes necessary measures to communicate the problems of Cancer effectively and find breakthrough to help people fight the disease strongly. We, as the company, work hard with high level of dedication and passion to integrate our resources to solve the critical issues of making the Anti-Cancer Medicines, Anti Cancer Tablets, Anti Cancer Injection available at each corner of India. Analytic based decision making helps us better understand the customer requirement and quickly resolve the issues. We engage with manufacturers having a large pool of scientist, and who are dedicated to unite against the deadly Cancer disease.

Key Facts :

Nature of Business

Exporter, Trader, Wholesaler, Distributor and Supplier

Year of Establishment


No. of Employees


Warehousing Facility



Nainital Bank

Annual Turnover

Rs 5 Crores



Our Product Portfolio

Biogen India offers following products:

  • Pharmaceutical Injections

    • Filgrastim Injection

    • Docetaxel Injection IP

    • Topotecan Injection IP

    • Irinotecan Injection IP

    • Paclitaxel Injection IP

    • Carboplatin Injection IP

    • Vinorelbine Injection IP

    • Trastuzumab For Injection

    • 2mg Bortezomib Injection IP

    • Erythropoietin Injection IP

    • Leucovorin Calcium Injection IP

    • PFS 300mcg Filgrastim Injection IP

    • Fludarabine Phosphate For Injection USP

    • 150mg Fosaprepitant Dimeglumine For Injection

  • Pharmaceutical Tablets

    • Flutamide Tablets IP

    • 4mg Dexamethasone Tablets

    • Abiraterone Acetate Tablets

    • Sacubitril Or Valsartan Tablets

    • Bethanechol Chloride Tablets USP

    • 40mg Megestrol Acetate Tablets IP

    • 10mg Tamoxifen Citrate Tablets IP

    • 160mg Megestrol Acetate Tablets IP

  • Pharmaceutical Capsules

    • Imatinib Capsules IP

    • Etoposide Capsules IP

    • 10mg Lenalidomide Capsules

  • Anti Cancer Medicines

"Our export market include Kenya, Oman, Dubai, Vietnam, Philippines, Hong Kong, Nigeria, Yemen, Ethiopia."